241 related articles for article (PubMed ID: 37627264)
1. Mass Spectrometry Imaging of In Vitro
Anschütz NH; Gerbig S; Ghezellou P; Silva LMR; Vélez JD; Hermosilla CR; Taubert A; Spengler B
Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627264
[No Abstract] [Full Text] [Related]
2. Atmospheric-pressure scanning microprobe matrix-assisted laser desorption/ionization mass spectrometry imaging of
Anschütz NH; Gerbig S; Ventura AMP; Silva LMR; Larrazabal C; Hermosilla C; Taubert A; Spengler B
Anal Sci Adv; 2022 Aug; 3(7-8):244-254. PubMed ID: 38716083
[No Abstract] [Full Text] [Related]
3. Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells.
Hashim A; Mulcahy G; Bourke B; Clyne M
Infect Immun; 2006 Jan; 74(1):99-107. PubMed ID: 16368962
[TBL] [Abstract][Full Text] [Related]
4. Comparative proteomics reveals Cryptosporidium parvum infection disrupts cellular barriers.
Wang L; Cui Z; Li N; Liang G; Zhang X; Wang Y; Li D; Li X; Zhang S; Zhang L
J Proteomics; 2023 Sep; 287():104969. PubMed ID: 37463621
[TBL] [Abstract][Full Text] [Related]
5. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
6. Combination of inhibitors for two glycolytic enzymes portrays high synergistic efficacy against
Khan SM; Bajwa MR; Lahar RY; Witola WH
Antimicrob Agents Chemother; 2023 Oct; 67(10):e0056923. PubMed ID: 37655889
[No Abstract] [Full Text] [Related]
7. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
[TBL] [Abstract][Full Text] [Related]
8. Molecular Targets of the 5-Amido-Carboxamide Bumped Kinase Inhibitor BKI-1748 in
Ajiboye J; Uldry AC; Heller M; Naguleswaran A; Fan E; Van Voorhis WC; Hemphill A; Müller J
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473953
[No Abstract] [Full Text] [Related]
9. The role of atypical MAP kinase 4 in the host interaction with Cryptosporidium parvum.
Watanabe N; Bando H; Murakoshi F; Sakurai R; Kabir MHB; Fukuda Y; Kato K
Sci Rep; 2023 Jan; 13(1):1096. PubMed ID: 36658270
[TBL] [Abstract][Full Text] [Related]
10. Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes.
Hashim A; Clyne M; Mulcahy G; Akiyoshi D; Chalmers R; Bourke B
Infect Immun; 2004 Oct; 72(10):6125-31. PubMed ID: 15385517
[TBL] [Abstract][Full Text] [Related]
11. Cryptosporidium parvum maintains intracellular survival by activating the host cellular EGFR-PI3K/Akt signaling pathway.
Yang H; Zhang M; Wang X; Gong P; Zhang N; Zhang X; Li X; Li J
Mol Immunol; 2023 Feb; 154():69-79. PubMed ID: 36621060
[TBL] [Abstract][Full Text] [Related]
12. The Cryptosporidium parvum gp60 glycoprotein expressed in the ciliate Tetrahymena thermophila is immunoreactive with sera of calves infected with Cryptosporidium oocysts.
Elguero ME; Tomazic ML; Montes MG; Florin-Christensen M; Schnittger L; Nusblat AD
Vet Parasitol; 2019 Jul; 271():45-50. PubMed ID: 31303202
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum.
Nava MG; Calderón F; Fernández E; Ballell L; Bamborough P; Vinayak S
Microbiol Spectr; 2023 Feb; 11(1):e0387422. PubMed ID: 36533912
[TBL] [Abstract][Full Text] [Related]
14. The Mucosal Innate Immune Response to
Crawford CK; Kol A
Front Cell Infect Microbiol; 2021; 11():689401. PubMed ID: 34113580
[No Abstract] [Full Text] [Related]
15. Comparative proteomics reveals Cryptosporidium parvum manipulation of the host cell molecular expression and immune response.
Li T; Liu H; Jiang N; Wang Y; Wang Y; Zhang J; Shen Y; Cao J
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009949. PubMed ID: 34818332
[TBL] [Abstract][Full Text] [Related]
16. Case Report: The impact of severe cryptosporidiosis on the gut microbiota of a pediatric patient with CD40L immunodeficiency.
Piazzesi A; Pane S; Russo A; Del Chierico F; Francalanci P; Cotugno N; Rossi P; Locatelli F; Palma P; Putignani L
Front Cell Infect Microbiol; 2023; 13():1281440. PubMed ID: 37965266
[No Abstract] [Full Text] [Related]
17. Comparison of in vitro growth characteristics of Cryptosporidium hominis (IdA15G1) and Cryptosporidium parvum (Iowa-IIaA17G2R1 and IIaA18G3R1).
Gunasekera S; Clode PL; King B; Monis P; Thierry B; Carr JM; Chopra A; Watson M; O'Dea M; Hijjawi N; Ryan U
Parasitol Res; 2023 Dec; 122(12):2891-2905. PubMed ID: 37776335
[TBL] [Abstract][Full Text] [Related]
18. Cryptosporidium parvum subtypes from diarrheic dairy calves in Israel.
Yasur-Landau D; Zilberberg M; Perry Markovich M; Behar A; Fleiderovitz L; Leszkowicz Mazuz M
Vet Parasitol Reg Stud Reports; 2021 Jul; 25():100608. PubMed ID: 34474801
[TBL] [Abstract][Full Text] [Related]
19. Identification of host protein ENO1 (alpha-enolase) interacting with Cryptosporidium parvum sporozoite surface protein, Cpgp40.
Wang Y; Li N; Liang G; Wang L; Zhang X; Cui Z; Li X; Zhang S; Zhang L
Parasit Vectors; 2024 Mar; 17(1):146. PubMed ID: 38504274
[TBL] [Abstract][Full Text] [Related]
20. Cryptosporidium parvum regulates HCT-8 cell autophagy to facilitate survival via inhibiting miR-26a and promoting miR-30a expression.
Jiang H; Zhang X; Li X; Wang X; Zhang N; Gong P; Zhang X; Yu Y; Li J
Parasit Vectors; 2022 Dec; 15(1):470. PubMed ID: 36522638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
